71 – 80 of 128
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
The cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in Spain. Comparison of clinical trial and clinical practice data.
(
- Contribution to journal › Article
-
Mark
Reliability and validity of the Fatigue Severity Scale in Swedish for patients with systemic lupus erythematosus
(
- Contribution to journal › Article
- 2007
-
Mark
The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review.
(
- Contribution to journal › Article
-
Mark
Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sjogren's syndrome
(
- Contribution to journal › Article
-
Mark
Rheumatoid arthritis: what does it cost and what factors are driving those costs? Results of a survey in a community-derived population in Malmo, Sweden
(
- Contribution to journal › Article
-
Mark
Simple counting of nailfold capillary density in suspected systemic sclerosis - 9 years' experience.
(
- Contribution to journal › Article
- 2006
-
Mark
Health economic issues in rheumatoid arthritis
(
- Contribution to journal › Scientific review
-
Mark
Progress and regression within primary Sjögren's syndrome.
(
- Contribution to journal › Article
-
Mark
Myocarditis in adult-onset Still's disease despite significant immunosuppressive therapy.
(
- Contribution to journal › Letter
- 2005
-
Mark
Change in and predictors of leisure activities among patients with rheumatoid arthritis: a prospective study.
(
- Contribution to journal › Article